The enzyme as drug: application of enzymes as pharmaceuticals
- PMID: 12943856
- DOI: 10.1016/s0958-1669(03)00092-2
The enzyme as drug: application of enzymes as pharmaceuticals
Abstract
Enzymes as drugs have two important features that distinguish them from all other types of drugs. First, enzymes often bind and act on their targets with great affinity and specificity. Second, enzymes are catalytic and convert multiple target molecules to the desired products. These two features make enzymes specific and potent drugs that can accomplish therapeutic biochemistry in the body that small molecules cannot. These characteristics have resulted in the development of many enzyme drugs for a wide range of disorders.
Similar articles
-
Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA).Immunodeficiency. 1993;4(1-4):93-7. Immunodeficiency. 1993. PMID: 8167743 Review. No abstract available.
-
Enzyme-assisted virectomy in enucleated pig eyes.Curr Eye Res. 2005 Oct;30(10):821-2; author reply 823-4. doi: 10.1080/02713680590968493. Curr Eye Res. 2005. PMID: 16251117 No abstract available.
-
Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency.J Allergy Clin Immunol. 2009 Oct;124(4):848-50. doi: 10.1016/j.jaci.2009.07.003. Epub 2009 Aug 8. J Allergy Clin Immunol. 2009. PMID: 19665771 No abstract available.
-
Effects of enzyme replacement therapy on immune function in ADA deficiency patient.Clin Immunol. 2015 Dec;161(2):391-3. doi: 10.1016/j.clim.2015.06.011. Epub 2015 Jun 27. Clin Immunol. 2015. PMID: 26122173 No abstract available.
-
Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy.Pediatr Res. 1993 Jan;33(1 Suppl):S42-7; discussion S47-8. doi: 10.1203/00006450-199305001-00236. Pediatr Res. 1993. PMID: 8433874 Review.
Cited by
-
QM/MM Description of Newly Selected Catalytic Bioscavengers Against Organophosphorus Compounds Revealed Reactivation Stimulus Mediated by Histidine Residue in the Acyl-Binding Loop.Front Pharmacol. 2018 Aug 3;9:834. doi: 10.3389/fphar.2018.00834. eCollection 2018. Front Pharmacol. 2018. PMID: 30123127 Free PMC article.
-
Portable Alkaline Phosphatase-Hydrogel Platform: From Enzyme Characterization to Phosphate Sensing.Int J Mol Sci. 2023 Jan 31;24(3):2672. doi: 10.3390/ijms24032672. Int J Mol Sci. 2023. PMID: 36769007 Free PMC article.
-
Bottlebrush Polymer-Conjugated Melittin Exhibits Enhanced Antitumor Activity and Better Safety Profile.ACS Appl Mater Interfaces. 2021 Sep 15;13(36):42533-42542. doi: 10.1021/acsami.1c14285. Epub 2021 Sep 2. ACS Appl Mater Interfaces. 2021. PMID: 34472829 Free PMC article.
-
A general strategy for the evolution of bond-forming enzymes using yeast display.Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11399-404. doi: 10.1073/pnas.1101046108. Epub 2011 Jun 22. Proc Natl Acad Sci U S A. 2011. PMID: 21697512 Free PMC article.
-
Nanofibrous Formulation of Cyclodextrin Stabilized Lipases for Efficient Pancreatin Replacement Therapies.Pharmaceutics. 2021 Jun 27;13(7):972. doi: 10.3390/pharmaceutics13070972. Pharmaceutics. 2021. PMID: 34199011 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources